| Literature DB >> 25679998 |
Sandro Manuel Mueller1, David Aguayo1, Matthias Zuercher1, Oliver Fleischmann1, Urs Boutellier1, Maria Auer2, Hans H Jung2, Marco Toigo1.
Abstract
UNLABELLED: Aerobic high-intensity interval training (HIT) improves cardiovascular capacity but may reduce the finite work capacity above critical power (W') and lead to atrophy of myosin heavy chain (MyHC)-2 fibers. Since whole-body vibration may enhance indices of anaerobic performance, we examined whether side-alternating whole-body vibration as a replacement for the active rest intervals during a 4 x 4 min HIT prevents decreases in anaerobic performance and capacity without compromising gains in aerobic function. Thirty-three young recreationally active men were randomly assigned to conduct either conventional 4 x 4 min HIT, HIT with 3 min of WBV at 18 Hz (HIT+VIB18) or 30 Hz (HIT+VIB30) in lieu of conventional rest intervals, or WBV at 30 Hz (VIB30). Pre and post training, critical power (CP), W', cellular muscle characteristics, as well as cardiovascular and neuromuscular variables were determined. W' (-14.3%, P = 0.013), maximal voluntary torque (-8.6%, P = 0.001), rate of force development (-10.5%, P = 0.018), maximal jumping power (-6.3%, P = 0.007) and cross-sectional areas of MyHC-2A fibers (-6.4%, P = 0.044) were reduced only after conventional HIT. CP, V̇O2peak, peak cardiac output, and overall capillary-to-fiber ratio were increased after HIT, HIT+VIB18, and HIT+VIB30 without differences between groups. HIT-specific reductions in anaerobic performance and capacity were prevented by replacing active rest intervals with side-alternating whole-body vibration, notably without compromising aerobic adaptations. Therefore, competitive cyclists (and potentially other endurance-oriented athletes) may benefit from replacing the active rest intervals during aerobic HIT with side-alternating whole-body vibration. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01875146.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25679998 PMCID: PMC4332652 DOI: 10.1371/journal.pone.0116764
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Representative images for mATPase and CD31 stainings in the whole-body vibration (VIB30), high-intensity interval training (HIT), and combined HIT and whole-body vibration at 18 Hz (HIT+VIB18) as well as at 30 Hz (HIT+VIB30) groups.
Black fibers, myosin heavy chain (MyHC)-1; grey fibers, MyHC-2A; intermediate fibers, MyHC-2X; brown dots, capillaries.
Finite work capacity above critical power (W′), maximal power during countermovement jumping (CMJ P max), maximal voluntary torque (MVT), and rate of force development (RFD) during the first 200 ms of contraction pre and post training in the 30 Hz WBV training (VIB30), high-intensity interval training (HIT), HIT with 18 Hz whole-body vibration (WBV; HIT+VIB18), and HIT with 30 Hz WBV (HIT+VIB30) group.
| VIB30 ( | HIT ( | HIT+VIB18 ( | HIT+VIB30 ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Change (%) | Pre | Post | Change (%) | Pre | Post | Change (%) | Pre | Post | Change (%) | |
|
| 17.8±6.3 | 19.0±5.7 | 7.7±13.9 | 19.2±3.5 | 16.4±3.6 | −14.3±11.8 | 18.7±5.8 | 18.1±4.0 | 0.8±24.3 | 17.7±6.4 | 17.1±6.4 | −3.4±8.2 |
| CMJ | 4.55±0.90 | 4.38±0.82 | −3.5±3.9 | 4.56±0.80 | 4.26±0.79 | −6.3±6.9 | 4.50±1.05 | 4.52±0.83 | 1.9±9.1 | 4.51±0.68 | 4.55±0.74 | 0.7±4.3 |
| MVT (Nm) | 176.2±26.0 | 178.1±15.4 | 2.1±10.6 | 178.7±24.7 | 163.9±27.4 | −8.6±5.7 | 185.1±30.4 | 184.7±35.2 | −0.5±3.0 | 179.0±26.4 | 173.5±30.3 | −4.6±5.8 |
| RFD (Nm∙s−1) | 1102±279 | 1116±250 | 3.1±14.5 | 1115±158 | 995±172 | −10.5±11.0 | 1199±236 | 1202±218 | 0.6±5.8 | 1142±253 | 1097±235 | −2.8±16.8 |
Values are mean ± SD.
*P < 0.05,
**P < 0.01, significant differences within group pre vs. post;
+ P = 0.067, difference between HIT and WBV group pre vs. post.
Distribution of the myosin heavy chains (MyHC) types and cross-sectional areas (CSA) pre and post training period in the 30 Hz whole-body vibration training (VIB30), the conventional 4x4 min high-intensity training (HIT), HIT with whole-body vibration at 18 Hz (HIT+VIB18) or 30 Hz (HIT+VIB30) instead of conventional rest intervals, groups.
| VIB30 ( | HIT ( | HIT+VIB18 ( | HIT+VIB30 ( | |||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
| MyHC-1 (%) | 49.7 ± 8.2 | 51.2 ± 13.3 | 56.2 ± 16.6 | 55.5 ± 12.7 | 48.4 ± 13.7 | 49.0 ± 13.9 | 57.2 ± 8.3 | 53.8 ± 8.7 |
| MyHC-2A (%) | 41.7 ± 10.6 | 43.6 ± 14.6 | 31.4 ± 9.0 | 37.8 ± 8.8 | 39.6 ± 9.9 | 45.1 ± 11.2 | 36.6 ± 9.3 | 44.0 ± 7.8 |
| MyHC-2X (%) | 8.6 ± 10.9 | 5.2 ± 5.5 | 12.4 ± 11.1 | 6.7 ± 6.7 | 12.0 ± 16.3 | 5.9 ± 7.8 | 6.2 ± 4.4 | 2.2 ± 2.3 |
| CSA MyHC-1 (μm2) | 4997 ± 941 | 4957 ± 1319 | 4568 ± 908 | 4439 ± 981 | 4341 ± 923 | 4407 ± 1024 | 4767 ± 625 | 4694 ± 702 |
| CSA MyHC-2A (μm2) | 5481 ± 766 | 5584 ± 1212 | 5764 ± 1122 | 5317 ± 798 | 5366 ± 1666 | 5436 ± 1896 | 5785 ± 974 | 6010 ± 922 |
Values are mean ± SD.
*P < 0.05,
**P < 0.01, significant differences within group pre vs. post training;
✝ P = 0.053 pre vs. post training.
Cycling power, overall capillary-to-fiber ratio, and cardiovascular variables pre and post training in the 30 Hz whole-body vibration (WBV) training (VIB30), high-intensity interval training (HIT), HIT with 18 Hz WBV (HIT+VIB18), and HIT with 30 Hz WBV (HIT+VIB30) groups.
| VIB30 ( | HIT ( | HIT+VIB18 ( | HIT+VIB30 ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Change (%) | Pre | Post | Change (%) | Pre | Post | Change (%) | Pre | Post | Change (%) | |
| CP (W) | 237.7±33.4 | 235.1±36.0 | −1.2±2.9 | 244.7±44.8 | 278.6±29.1 | 15.4±10.3 | 242.3±37.4 | 266.5±41.9 | 9.9±2.2 | 252.8±34.5 | 275.3±29.8 | 9.3±5.5 |
|
| 331.8±34.3 | 335.1±39.5 | 0.9±2.9 | 354.3±37.2 | 382.5±29.0 | 8.4±5.9 | 340.0±46.9 | 375.6±46.4 | 10.7±3.6 | 357.0±33.1 | 380.0±32.8 | 6.6±4.3 |
| Overall capillary-to-fiber ratio | 1.75±0.23 | 1.77±0.14 | 1.1±1.5 | 1.74±0.28 | 1.83±0.24 | 5.5±5.0 | 1.66±0.27 | 1.79±0.26 | 8.4±5.9 | 1.83±0.22 | 1.94±0.25 | 6.4±3.6 |
| ˙ | 3.82±0.52 | 3.83±0.50 | 0.1±1.3 | 3.83±0.30 | 4.02±0.29 | 5.2±4.7 | 3.84±0.53 | 4.05±0.49 | 6.0±8.3 | 3.95±0.39 | 4.12±0.38 | 4.5±1.9 |
| Peak cardiac output (l∙min−1) | 17.8±4.5 | 18.0±3.0 | 3.9±15.8 | 17.7±3.5 | 19.2±3.6 | 9.2±11.5 | 16.6±3.1 | 18.1±3.3 | 9.4±3.3 | 17.8±3.6 | 19.4±3.2 | 8.2±6.2 |
| Peak stroke volume (ml) | 100.8±27.0 | 99.9±15.4 | 3.9±17.0 | 92.6±16.0 | 102.0±17.2 | 11.2±13.0 | 88.3±17.1 | 97.9±19.0 | 10.9±3.5 | 94.0±20.1 | 105.6±18.2 | 11.5±7.8 |
| Peak heart rate (min−1) | 180.5±7.2 | 180.3±6.1 | −0.1±3.3 | 186.3±9.0 | 182.6±5.2 | −1.9±2.5 | 188.9±4.2 | 185.5±3.6 | −1.8±2.0 | 189.4±4.6 | 183.2±4.941 | −3.3±1.7 |
Values are mean ± SD. CP, critical power; P peak, peak cycling power; V̇O2peak, peak oxygen uptake.
*P < 0.05,
**P < 0.01,
***P < 0.001 significant differences within group pre vs. post;
# P < 0.05,
## P < 0.05,
### P < 0.001 difference between group and VIB30 group pre vs. post training.
Average values for power, heart rate (HR), oxygen uptake (V̇O2), blood lactate concentration ([La−]), and ratings of perceived exertion (PE) during the high-intensity intervals (HI) and rest intervals (RI) during the 1st and 20th training session for the high-intensity interval training (HIT), HIT+VIB18, and HIT+VIB30 groups.
| 1st Training | 20th Training | |||||
|---|---|---|---|---|---|---|
| HIT ( | HIT+VIB18 ( | HIT+VIB30 ( | HIT ( | HIT+VIB18 ( | HIT+VIB30 ( | |
| Power HI (W) | 254.2 ± 30.9 | 247.1 ± 42.1 | 251.5 ± 30.2 | 284.9 ± 24.0 | 279.8 ± 36.9 | 285.5 ± 22.8 |
| HR HI (min−1) | 172.9 ± 10.0 | 170.9 ± 5.1 | 171.3 ± 6.8 | 171.4 ± 5.9 | 170.3 ± 5.6 | 166.4 ± 7.1 |
| HR HI (%peak HR) | 92.8 ± 2.0 | 90.5 ± 2.3 | 90.4 ± 1.9 | 93.8 ± 1.6 | 91.8 ± 1.9 | 90.8 ± 2.4 |
| HR RI (min−1) | 164.0 ± 13.0 | 157.9 ± 9.1 | 154.0 ± 10.9 | 163.3 ± 5.9 | 152.5 ± 9.4 | 146.6 ± 11.2 |
| HR RI (%peak HR) | 88.0 ± 4.7 | 83.6 ± 4.9 | 81.2 ± 3.8 | 89.4 ± 2.9 | 82.2 ± 4.6 | 79.9 ± 4.1 |
|
| 3.29 ± 0.25 | 3.24 ± 0.48 | 3.34 ± 0.44 | 3.65 ± 0.39 | 3.57 ± 0.33 | 3.57 ± 0.33 |
|
| 86.1 ± 4.8 | 84.3 ± 4.0 | 84.5 ± 7.2 | 88.1 ± 10.8 | 88.6 ± 6.6 | 84.1 ± 6.2 |
|
| 2.78 ± 0.16 | 1.87 ± 0.25 | 1.96 ± 0.20 | 2.97 ± 0.28 | 1.86 ± 0.31 | 1.89 ± 0.19 |
|
| 72.9 ± 4.1 | 47.2 ± 5.4 | 49.7 ± 4.3 | 71.6 ± 7.4 | 44.4 ± 5.9 | 44.5 ± 4.1 |
| [La−] (mmol∙l−1) | 9.73 ± 3.23 | 10.60 ± 1.95 | 11.17 ± 2.06 | 11.95 ± 2.56 | 12.75 ± 2.38 | 11.73 ± 2.40 |
| PE breathlessness | 3.5 ± 2.2 | 5.6 ± 3.2 | 3.8 ± 2.4 | 6.2 ± 3.3 | 7.4 ± 3.1 | 6.4 ± 2.9 |
| PE respiratory exertion | 6.0 ± 2.2 | 7.2 ± 1.9 | 5.6 ± 2.6 | 7.8 ± 2.2 | 8.5 ± 0.9 | 8.0 ± 1.7 |
| PE leg exertion | 7.1 ± 1.9 | 6.5 ± 0.6 | 5.9 ± 2.5 | 7.9 ± 2.0 | 7.7 ± 2.0 | 7.3 ± 2.3 |
| PE Pain | 4.0 ± 2.5 | 4.2 ± 3.3 | 2.8 ± 2.5 | 7.2 ± 2.1 | 5.6 ± 4.0 | 4.0 ± 3.9 |
Values are mean ± SD.
*P < 0.05,
***P < 0.001, significant differences relative to HIT training group.